Moderator
Bashni Reddy, PharmD, OPEN Health, New York, NY, United States
Speakers
Gregory Daniel, MPH, PhD, Eli Lilly & Co. Ltd., Washington, DC, United States; Sang Mi Lee, MBA, RPh, MORSE Consulting Inc., Toronto, ON, Canada; Andrew Briggs, DPhil, London School of Hygiene & Tropical Medicine, London, United Kingdom
This educational symposium, which builds on our session from ISPOR in Montreal, will examine recent and emerging healthcare policy developments, including but not limited to MFN pricing, across multiple jurisdictions, focusing on the impact of these healthcare policy changes beyond the US border.
Speakers from UK, US and Canada will explore the short- and long-term implications of evolving healthcare policy reforms, and discuss how, in an increasingly interconnected global healthcare policy environment, policy developments in one jurisdiction may influence evidence requirements, pricing frameworks, and access pathways in others, highlighting implications for health technology assessment, payer decision-making, and global evidence strategies.
Sponsored by Corporate Partner, OPEN Health
Topic
Health Policy & Regulatory, Health Technology Assessment, Organizational Practices